Operating Income (Loss) in USD of Liminatus Pharma, Inc. from Q1 2024 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Liminatus Pharma, Inc. quarterly Operating Income (Loss) history and change rate from Q1 2024 to Q3 2025.
Liminatus Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$701K, a 29.1% decline year-over-year.

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Change (%)

Liminatus Pharma, Inc. Quarterly Operating Income (Loss) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2025		-$701K	-$158K	-29.1%	Jul 1, 2025	Sep 30, 2025	10-Q	2025-11-14
Q2 2025		-$1.12M	-$209K	-23%	Apr 1, 2025	Jun 30, 2025	10-Q	2025-10-06
Q1 2025		-$255^*	-$8		Jan 1, 2025	Mar 31, 2025	10-Q	2025-06-02
Q3 2024		-$543K			Jul 1, 2024	Sep 30, 2024	10-Q	2025-11-14
Q2 2024		-$909K			Apr 1, 2024	Jun 30, 2024	10-Q	2025-10-06
Q1 2024		-$247^*			Jan 1, 2024	Mar 31, 2024	10-Q	2025-06-02

* An asterisk sign (*) next to the value indicates that the value is likely invalid.